Genomic Classifier in Prostate Cancer: High-Risk

Combining PSMA PET and Genomic Risk Assessment in High-Risk Prostate Cancer - Sophia Coraci

Analysis of Genomic Drivers of Discordant Risk Classifications in Prostate Cancer - Michael Zelefsky

Treatment Intensification Strategies for High-Risk Prostate Cancer Patients - Aaron Berger

Combining Genomic Classifier and Digital Pathology Artificial Intelligence in Prostate Cancer Risk Stratification - Daniel Spratt

Precision Risk Assessment in Prostate Cancer: Growing Utility in NCCN Guidelines - Rashid Sayyid & Zachary Klaassen

Deciphering Prostate Cancer: How Genomic Biomarkers are Shaping Treatment Decisions - Paul Nguyen

Correlation and Validation of Gene Expression Classifiers in Prostate Cancer: A Large-Scale Study - Daniel Spratt

Decipher® Scores and PSMA PET Imaging: A Correlative Study in High-Risk Prostate Cancer - Amar Kishan

Integrating the Use of Prostate Genomic Classifiers into Clinical Practice - A Clinical Pathway Approach - Katie Murray and Anne Lizardi-Calvaresi

Transcriptome-Based Prognostic and Predictive Biomarker Analysis - The DECIPHER® Genomic Classifier for Prostate Cancer - Ashley Ross

Insights from the STAMPEDE Trial Platform - Marina Parry & Gerhardt Attard

The Molecular Biology of Prostate Cancer - Christopher Barbieri

An Ancillary Study of the STAMPEDE Trial Assessing the Clinical Qualification of Transcriptome Signatures for Advanced Prostate Cancer Starting ADT +/- Abiraterone Acetate and Prednisolone - Gerhardt Attard

The Use of the Decipher® Biopsy Test Prior to Prostatectomy - Ashley Ross

High Risk Prostate Cancer and Genomics - Paul Nguyen & Alan Pollack